As far as I know there are 2 instos on the register that have come on since IPO. As a general note, a lot of instos have mandates that will not allow them to invest in pre-revenue companies with smaller market caps.
I myself am a top 20 holder and have added significantly since listing. Yes, liquidity is an issue for anyone wanting a large line of stock but I’m happy to live with the ups and downs of this. Bring on the non-dilutive funding, mgmt are def looking after long term loyal shareholders.
Rolling, it must also be noted that mgmt have a lot of skin in the game here and haven’t sold a single share. Your comment about destroying wealth is ridiculous and very short term.
Ann: Clinical Trial Stage 1 Enrolment Completed, page-18
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.12 |
Change
-0.030(1.40%) |
Mkt cap ! $181.1M | |||
| Open | High | Low | Value | Volume |
| $2.15 | $2.18 | $2.10 | $93.15K | 43.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 194 | $2.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.15 | 11452 | 1 |
View Market Depth
| Last trade - 15.51pm 16/08/2024 (20 minute delay) ? |
| EMV (ASX) Chart |